A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Clinical Trials, Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06238479
Phase: PHASE1
Trial Summary: The purpose of this study is to find out whether the study drug, LY4101174, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors. The study is conducted in two pa – see clinicaltrials.gov for information and location
Clinicaltrials.gov
Trial Sponsor(s): Eli Lilly and Company
Acronym:

Pin It on Pinterest